AMAT vs MDGL · P/E 56, rev $24.04B vs rev $675.6M
Applied Materials Inc (AMAT) versus Madrigal Pharmaceuticals Inc (MDGL) — a side-by-side from cached financials, not a winner call.
Applied Materials Inc (AMAT) is a semiconductor equipment & materials company listed on NASDAQ.
Madrigal Pharmaceuticals Inc (MDGL) is a biotechnology company listed on NASDAQ.
Latest reported AMAT revenue for 2026-07-26 was $24.04B. Net income was $7.37B. AMAT currently screens at market cap $470.75B and trailing P/E 55.8.
Latest reported MDGL revenue for 2026-06-30 was $675.6M. Net income was -$152.3M. MDGL currently screens at market cap $11.56B.
AMAT currently screens at market cap $470.75B and trailing P/E 55.8. MDGL currently screens at market cap $11.56B.
Not investment advice. Open the AMAT and MDGL stock pages for the full models.
Not investment advice.